Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.

Chase, T N

Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism. [electronic resource] - Neurology Apr 1972 - 384-92 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0028-3878

10.1212/wnl.22.4.384 doi


Adolescent
Adult
Aged
Blood Pressure
Brain--metabolism
Child
Dihydroxyphenylalanine--therapeutic use
Dopamine--metabolism
Evaluation Studies as Topic
Female
Gastrointestinal Diseases--etiology
Heart--drug effects
Humans
Hydrazines--adverse effects
Hydroxyindoleacetic Acid--cerebrospinal fluid
Male
Methyldopa--adverse effects
Middle Aged
Motor Skills--drug effects
Parkinson Disease--drug therapy
Phenylacetates--cerebrospinal fluid
Serotonin--metabolism